about
Aptamer for imaging and therapeutic targeting of brain tumor glioblastomaPhage display discovery of novel molecular targets in glioblastoma-initiating cellsDNA Aptamer Technology for Personalized Medicine.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersABC transporters in CSCs membranes as a novel target for treating tumor relapse.Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface AntigensEts1 identified as a novel molecular target of RNA aptamer selected against metastatic cells for targeted delivery of nano-formulation.Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discoInhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.The Optimization and Characterization of an RNA-Cleaving Fluorogenic DNAzyme Probe for MDA-MB-231 Cell Detection.Therapy-induced enrichment of putative lung cancer stem-like cells.Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment.Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells.Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells.Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.Aptamer Cell-Based Selection: Overview and Advances.Aptamers: novelty tools for cancer biology.A Critical Overview of Targeted Therapies for Glioblastoma
P2860
Q26799218-CB76F457-15EA-496A-9820-F0C281C5B088Q28240138-E180AA66-90FC-49BD-A753-55DEFE27D7ABQ30412965-49A34EC5-6BA2-4456-B6C8-CF8689F642A1Q33832781-95E6AEA7-5108-49B4-9345-56ABA5B0651BQ33879326-3EA5B03A-AC6D-406B-B94F-109AC884BC0CQ36266158-1291D955-D01F-4F5C-A09A-D31B303AC188Q36394059-D07E70EA-3590-464F-9EF6-E1332471A3AEQ37665234-3A9A83F5-D1AE-445B-A6F3-37966B3ACFADQ37696048-7BCB62E9-D94C-415A-A734-C48C4A72EDACQ37732846-7735AB66-D8E4-463C-A34F-170602D5FAD6Q38150766-204ADDC0-980B-4EBE-86C5-EABE290BC1B7Q38212216-2F0676F1-43D0-43EB-A17C-79300DB2F81DQ38288126-FD5BE585-CC9D-4BF5-898E-E05C77227CAEQ47161416-6C5DCE7B-60DF-4BB0-A84C-2267479C37C3Q47168257-24BCFABE-6747-47F8-B4F3-546296C4E2E5Q47942947-6AFC0BE5-77F3-4205-8EEE-88B57E38CDF1Q52544489-9CE64B22-A74F-4470-AA8A-030C5801475AQ55285633-B3523F94-4BD8-4724-812C-C28DF49EF958Q58122179-7B92E703-66D3-4E34-A853-43AE7C8EC984
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aptamer identification of brain tumor-initiating cells.
@en
Aptamer identification of brain tumor-initiating cells.
@nl
type
label
Aptamer identification of brain tumor-initiating cells.
@en
Aptamer identification of brain tumor-initiating cells.
@nl
prefLabel
Aptamer identification of brain tumor-initiating cells.
@en
Aptamer identification of brain tumor-initiating cells.
@nl
P2093
P2860
P1433
P1476
Aptamer identification of brain tumor-initiating cells.
@en
P2093
Andrew E Sloan
Jeremy N Rich
Masahiro Hitomi
Patrick Leahy
Petra Hamerlik
Qiulian Wu
Robert J Weil
Youngmi Kim
P2860
P304
P356
10.1158/0008-5472.CAN-12-4556
P407
P577
2013-06-24T00:00:00Z